FDA Grants Full Approval of Deciphera Pharmaceuticals' QINLOCK (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

Media coverage

• Title	FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
  Media name/outlet	PipelineReview
  Country/Territory	Spain
  Date	05/16/20
  URL	https://pipelinereview.com/index.php/2020051674652/Small-Molecules/FDA-Grants-Full-Approval-of-Deciphera-Pharmaceuticals-QINLOCK-ripretinib-for-the-Treatment-of-Fourth-Line-Gastrointestinal-Stromal-Tumor.html
  Persons	Margaret von Mehren

• Title	FDA Grants Full Approval of Deciphera Pharmaceuticals' QINLOCK (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	05/15/20
  Persons	Margaret von Mehren